Cargando…

Is miR-29 an oncogene or tumor suppressor in CLL?

B-cell chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL occurs in two forms, aggressive and indolent. Aggressive CLL is characterized by high ZAP-70 expression and unmutated IgH V(H); indolent CLL shows low ZAP-70 expression and mutated IgH V(H). We recently f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pekarsky, Yuri, Croce, Carlo M.
Formato:	Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2010
Materias:	Research Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951328/ https://www.ncbi.nlm.nih.gov/pubmed/20936047

Ejemplares similares

The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?
por: Wurm, Alexander Arthur, et al.
Publicado: (2017)

PDCD1 (PD-1) is a direct target of miR-15a-5p and miR-16-5p
por: Palamarchuk, Alexey, et al.
Publicado: (2022)

A large fraction of trisomy 12, 17p(−), and 11q(−) CLL cases carry unidentified microdeletions of miR-15a/16-1
por: Pepe, Felice, et al.
Publicado: (2022)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

KRAS-driven miR-29b expression is required for tumor suppressor gene silencing
por: Thakur, Shilpa, et al.
Publicado: (2017)

MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
por: Visone, Rosa, et al.
Publicado: (2012)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers
por: Elliman, S J, et al.
Publicado: (2014)

miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis
por: Shi, Cuijuan, et al.
Publicado: (2018)

The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
por: Zhu, Shuo, et al.
Publicado: (2021)

Hepatic miR-29ab1 expression modulates chronic hepatic injury
por: Kogure, Takayuki, et al.
Publicado: (2012)

MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis
por: Nan, Ping, et al.
Publicado: (2019)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer
por: Gu, Yuanyuan, et al.
Publicado: (2017)

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
por: Guo, Li-Hua, et al.
Publicado: (2013)

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
por: Rivas, Martin A, et al.
Publicado: (2012)

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
por: Kojima, S, et al.
Publicado: (2012)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

miRNA signature of schwannomas: Possible role(s) of “tumor suppressor” miRNAs in benign tumors
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2011)

MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer
por: Liu, Xiangxiang, et al.
Publicado: (2018)

MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia
por: Sun, Hongbo, et al.
Publicado: (2020)

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
por: Bresin, Antonella, et al.
Publicado: (2015)

MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction]
Publicado: (2023)

Retraction: The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2019)

Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
por: Shao, Yang, et al.
Publicado: (2016)

Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo
por: Jain, Abhinav K, et al.
Publicado: (2012)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021)

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion
por: Wu, Xun, et al.
Publicado: (2021)

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs
por: Rashed, Mohammed H, et al.
Publicado: (2017)

The role of miR‐29 family in disease
por: Horita, Masahiro, et al.
Publicado: (2021)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

MiR-22 as a metabolic silencer and liver tumor suppressor
por: Wang, Lijun, et al.
Publicado: (2020)

The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer
por: Rana, Priyanka S., et al.
Publicado: (2023)

miR-124, a potential therapeutic target in colorectal cancer
por: Qin, Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vgoprcgs20h4ttvssispba2j5e